Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | JNJ-69086420 |
Trade Name | |
Synonyms | JNJ69086420|JNJ 69086420|JNJ-6420|JNJ6420|JNJ 6420 |
Drug Descriptions |
JNJ-69086420 is a radiotherapy comprising an antibody targeting KLK2 (hK2) linked to actinium-225, which potentially decreases tumor growth (J Clin Oncol 42, 2024 (suppl 16; abstr 5010). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C176627 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
JNJ-69086420 | JNJ-69086420 | 0 | 1 |